PT  - JOURNAL ARTICLE
AU  - Chunxue Bai
AU  - Sanjay H. Chotirmall
AU  - Jordi Rello
AU  - George A. Alba
AU  - Leo C. Ginns
AU  - Jerry A. Krishnan
AU  - Robert Rogers
AU  - Elisabeth Bendstrup
AU  - Pierre-Regis Burgel
AU  - James D. Chalmers
AU  - Abigail Chua
AU  - Kristina A. Crothers
AU  - Abhijit Duggal
AU  - Yeon Wook Kim
AU  - John G. Laffey
AU  - Carlos M. Luna
AU  - Michael S. Niederman
AU  - Ganesh Raghu
AU  - Julio A. Ramirez
AU  - Jordi Riera
AU  - Oriol Roca
AU  - Maximiliano Tamae-Kakazu
AU  - Antoni Torres
AU  - Richard R. Watkins
AU  - Miriam Barrecheguren
AU  - Mirko Belliato
AU  - Hassan A. Chami
AU  - Rongchang Chen
AU  - Gustavo A. Cortes-Puentes
AU  - Charles Delacruz
AU  - Margaret M. Hayes
AU  - Leo M.A. Heunks
AU  - Steven R. Holets
AU  - Catherine L. Hough
AU  - Sugeet Jagpal
AU  - Kyeongman Jeon
AU  - Takeshi Johkoh
AU  - May M. Lee
AU  - Janice Liebler
AU  - Gerry N. McElvaney
AU  - Ari Moskowitz
AU  - Richard A. Oeckler
AU  - Iñigo Ojanguren
AU  - Anthony O'Regan
AU  - Mathias W. Pletz
AU  - Chin Kook Rhee
AU  - Marcus J. Schultz
AU  - Enrico Storti
AU  - Charlie Strange
AU  - Carey C. Thomson
AU  - Francesca J. Torriani
AU  - Xun Wang
AU  - Wim Wuyts
AU  - Tao Xu
AU  - Dawei Yang
AU  - Ziqiang Zhang
AU  - Kevin C. Wilson
TI  - Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)
AID  - 10.1183/16000617.0287-2020
DP  - 2020 Sep 30
TA  - European Respiratory Review
PG  - 200287
VI  - 29
IP  - 157
4099  - http://err.ersjournals.com/content/29/157/200287.short
4100  - http://err.ersjournals.com/content/29/157/200287.full
SO  - EUROPEAN RESPIRATORY REVIEW2020 Sep 30; 29
AB  - Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome-coronavirus-2. Consensus suggestions can standardise care, thereby improving outcomes and facilitating future research.Methods An International Task Force was composed and agreement regarding courses of action was measured using the Convergence of Opinion on Recommendations and Evidence (CORE) process. 70% agreement was necessary to make a consensus suggestion.Results The Task Force made consensus suggestions to treat patients with acute COVID-19 pneumonia with remdesivir and dexamethasone but suggested against hydroxychloroquine except in the context of a clinical trial; these are revisions of prior suggestions resulting from the interim publication of several randomised trials. It also suggested that COVID-19 patients with a venous thromboembolic event be treated with therapeutic anticoagulant therapy for 3 months. The Task Force was unable to reach sufficient agreement to yield consensus suggestions for the post-hospital care of COVID-19 survivors. The Task Force fell one vote shy of suggesting routine screening for depression, anxiety and post-traumatic stress disorder.Conclusions The Task Force addressed questions related to pharmacotherapy in patients with COVID-19 and the post-hospital care of survivors, yielding several consensus suggestions. Management options for which there is insufficient agreement to formulate a suggestion represent research priorities.For patients with acute COVID-19 pneumonia who require oxygen support, the International Task Force made suggestions for remdesivir and dexamethasone, but against hydroxychloroquine. Post-discharge management of COVID-19 survivors is a research priority. https://bit.ly/32B96uI